{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:29:33Z","timestamp":1794274173521,"version":"4.9.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100019870","name":"Cancer Foundation of China","doi-asserted-by":"publisher","award":["LC2018L04"],"award-info":[{"award-number":["LC2018L04"]}],"id":[{"id":"10.13039\/501100019870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005149","name":"Chinese Academy of Medical Sciences Cancer Institute and Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2022020714463802"],"award-info":[{"award-number":["2022020714463802"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.labinv.2026.106079","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:13:06Z","timestamp":1771027986000},"page":"106079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["High-Resolution Spatial Transcriptomic Characterization of Syncytial Variant of Nodular Sclerosis Classical Hodgkin Lymphoma"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5595-3761","authenticated-orcid":false,"given":"Xiaoyue","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5663-6006","authenticated-orcid":false,"given":"Xiaoli","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.labinv.2026.106079_bib1","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/ajh.26717","article-title":"Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management","volume":"97","author":"Ansell","year":"2022","journal-title":"Am J Hematol"},{"issue":"35","key":"10.1016\/j.labinv.2026.106079_bib2","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1200\/JCO.20.00264","article-title":"Cause-specific mortality following initial chemotherapy in a population-based cohort of patients with classical Hodgkin lymphoma, 2000-2016","volume":"38","author":"Dores","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106079_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-020-0189-6","article-title":"Hodgkin lymphoma","volume":"6","author":"Connors","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.labinv.2026.106079_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/bjh.15614","article-title":"Diagnosis of Hodgkin lymphoma in the modern era","volume":"184","author":"Wang","year":"2019","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.labinv.2026.106079_bib5","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/1097-0142(19891015)64:8<1686::AID-CNCR2820640822>3.0.CO;2-I","article-title":"Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin\u2019s disease. A study of 1659 patients","volume":"64","author":"MacLennan","year":"1989","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.labinv.2026.106079_bib6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1365-2141.1997.d01-2010.x","article-title":"Disappearance of prognostic significance of histopathological grading of nodular sclerosing Hodgkin\u2019s disease for unselected patients, 1972-92","volume":"96","author":"van Spronsen","year":"1997","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.labinv.2026.106079_bib7","first-page":"581","article-title":"Pathological characteristics and clinical prognosis of nodular sclerosis grade 2 of classic Hodgkin\u2019s lymphoma","volume":"44","author":"Xue","year":"2022","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1016\/j.labinv.2026.106079_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.humpath.2021.11.007","article-title":"Clinicopathological features of syncytial variant nodular sclerosis Hodgkin lymphoma","volume":"119","author":"Zhang","year":"2022","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106079_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2040620716676256","article-title":"Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma","volume":"8","author":"Sethi","year":"2017","journal-title":"Ther Adv Hematol"},{"issue":"17","key":"10.1016\/j.labinv.2026.106079_bib10","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1158\/1078-0432.CCR-24-0942","article-title":"Multiplexed spatial profiling of Hodgkin Reed-Sternberg cell neighborhoods in classic Hodgkin lymphoma","volume":"30","author":"Pourmaleki","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.labinv.2026.106079_bib11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood-2018-04-843714","article-title":"Mass cytometry of Hodgkin lymphoma reveals a CD4(+) regulatory T-cell-rich and exhausted T-effector microenvironment","volume":"132","author":"Cader","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.labinv.2026.106079_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","article-title":"Single-cell transcriptome analysis reveals disease-defining T-cell subsets in the tumor microenvironment of classic Hodgkin lymphoma","volume":"10","author":"Aoki","year":"2020","journal-title":"Cancer Discov"},{"issue":"15","key":"10.1016\/j.labinv.2026.106079_bib13","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood.2022017147","article-title":"Novel insights into Hodgkin lymphoma biology by single-cell analysis","volume":"141","author":"Aoki","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.labinv.2026.106079_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ccell.2025.02.009","article-title":"Single-cell multi-stage spatial evolutional map of esophageal carcinogenesis","volume":"43","author":"Chang","year":"2025","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.labinv.2026.106079_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat Biotechnol"},{"issue":"17","key":"10.1016\/j.labinv.2026.106079_bib16","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood-2012-06-439570","article-title":"Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma","volume":"120","author":"Steidl","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.labinv.2026.106079_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"Wykes","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106079_bib18","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41467-021-22300-2","article-title":"Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling","volume":"12","author":"Hu","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.labinv.2026.106079_bib19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/cac2.12429","article-title":"Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer","volume":"43","author":"Ding","year":"2023","journal-title":"Cancer Commun (Lond)"},{"issue":"3","key":"10.1016\/j.labinv.2026.106079_bib20","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.labinv.2026.106079_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41408-024-01199-0","article-title":"Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed\/refractory angioimmunoblastic T-cell lymphoma","volume":"14","author":"Zhu","year":"2024","journal-title":"Blood Cancer J"},{"issue":"D1","key":"10.1016\/j.labinv.2026.106079_bib22","doi-asserted-by":"crossref","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"10.1016\/j.labinv.2026.106079_bib23","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.labinv.2026.106079_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41408-019-0195-7","article-title":"Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma","volume":"9","author":"Mata","year":"2019","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.labinv.2026.106079_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1634\/theoncologist.2018-0058","article-title":"Comprehensive genomic profiling of Hodgkin lymphoma reveals recurrently mutated genes and increased mutation burden","volume":"24","author":"Liang","year":"2019","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.labinv.2026.106079_bib26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/path.1725","article-title":"Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin\u2019s lymphoma cells through a mechanism involving Akt kinase and mTOR","volume":"205","author":"Dutton","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.labinv.2026.106079_bib27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1471-2407-13-250","article-title":"Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease\u2014a combined tissue microarray, in vitro and in vivo study","volume":"13","author":"M\u00e1rk","year":"2013","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.labinv.2026.106079_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12935-018-0610-3","article-title":"PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression","volume":"18","author":"Xie","year":"2018","journal-title":"Cancer Cell Int"},{"issue":"4","key":"10.1016\/j.labinv.2026.106079_bib29","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","article-title":"Molecular biology of Hodgkin lymphoma","volume":"35","author":"Weniger","year":"2021","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.labinv.2026.106079_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8(+) T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.labinv.2026.106079_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.addr.2018.12.005","article-title":"Targeting the CD40-CD40L pathway in autoimmune diseases: humoral immunity and beyond","volume":"141","author":"Karnell","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.labinv.2026.106079_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116231","article-title":"The BTLA-HVEM complex\u2014the future of cancer immunotherapy","volume":"268","author":"Wojciechowicz","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"80","key":"10.1016\/j.labinv.2026.106079_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add1823","article-title":"IL-21R signal reprogramming cooperates with CD40 and BCR signals to select and differentiate germinal center B cells","volume":"8","author":"Luo","year":"2023","journal-title":"Sci Immunol"},{"issue":"19","key":"10.1016\/j.labinv.2026.106079_bib34","first-page":"2343","article-title":"Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma","volume":"141","author":"Stewart","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.labinv.2026.106079_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40364-025-00775-1","article-title":"Targeting myeloid cells for hematological malignancies: the present and future","volume":"13","author":"Guan","year":"2025","journal-title":"Biomark Res"},{"issue":"1","key":"10.1016\/j.labinv.2026.106079_bib36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mdr2.70001","article-title":"Systematic investigation of tumor microenvironment and antitumor immunity with IOBR","volume":"1","author":"Fang","year":"2025","journal-title":"Med Research"},{"issue":"4","key":"10.1016\/j.labinv.2026.106079_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.curpro.2025.100034","article-title":"Multi-omics analysis reveals molecular characteristics and potential therapeutic targets of primary central nervous system lymphoma","volume":"22","author":"Li","year":"2025","journal-title":"Curr Proteomics"},{"issue":"2","key":"10.1016\/j.labinv.2026.106079_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10238-015-0350-9","article-title":"Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity","volume":"16","author":"Peng","year":"2016","journal-title":"Clin Exp Med"},{"issue":"4","key":"10.1016\/j.labinv.2026.106079_bib39","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood.2021012091","article-title":"PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma","volume":"139","author":"Liu","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.labinv.2026.106079_bib40","doi-asserted-by":"crossref","DOI":"10.2174\/1874467217666230908111754","article-title":"At the Crossroads of TNF \u03b1 Signaling and Cancer","volume":"17","author":"Manohar","year":"2023","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106079_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-017-0500-x","article-title":"PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancer","volume":"36","author":"Peng","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.labinv.2026.106079_bib42","doi-asserted-by":"crossref","first-page":"19868","DOI":"10.1002\/jcb.29292","article-title":"Declination of long noncoding RNA paternally expressed gene 10 inhibits A375 cells proliferation, migration, and invasion via mediating microRNA-33a","volume":"120","author":"Fu","year":"2019","journal-title":"J Cell Biochem"},{"issue":"11","key":"10.1016\/j.labinv.2026.106079_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10110415","article-title":"Profiling immune escape in Hodgkin\u2019s and diffuse large B-cell lymphomas using the transcriptome and immunostaining","volume":"10","author":"P\u00e9ricart","year":"2018","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.labinv.2026.106079_bib44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/blood.2019000847","article-title":"The immune landscape and response to immune checkpoint blockade therapy in lymphoma","volume":"135","author":"Kline","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.labinv.2026.106079_bib45","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2326-6066.CIR-17-0325","article-title":"Complex immune evasion strategies in classical Hodgkin lymphoma","volume":"5","author":"Wein","year":"2017","journal-title":"Cancer Immunol Res"},{"issue":"6230","key":"10.1016\/j.labinv.2026.106079_bib46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.labinv.2026.106079_bib47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/bjh.18473","article-title":"Thymus and activation-regulated chemokine (TARC) as treatment response marker for paediatric Hodgkin lymphoma: A pilot study","volume":"200","author":"Zijtregtop","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.labinv.2026.106079_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156412","article-title":"BTLA and HVEM: emerging players in the tumor microenvironment and cancer progression","volume":"172","author":"Mohamed","year":"2023","journal-title":"Cytokine"},{"issue":"14","key":"10.1016\/j.labinv.2026.106079_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17142292","article-title":"Immune checkpoint molecules in Hodgkin lymphoma and other hematological malignancies","volume":"17","author":"Alibrahim","year":"2025","journal-title":"Cancers"},{"issue":"14","key":"10.1016\/j.labinv.2026.106079_bib50","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1182\/blood.2023022197","article-title":"Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma","volume":"145","author":"Gottschlich","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.labinv.2026.106079_bib51","doi-asserted-by":"crossref","first-page":"0723","DOI":"10.34133\/research.0723","article-title":"Natural killer cell immune checkpoints and their therapeutic targeting in cancer treatment","volume":"8","author":"Lin","year":"2025","journal-title":"Research"},{"issue":"12","key":"10.1016\/j.labinv.2026.106079_bib52","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/leu.2016.226","article-title":"Human memory B cells","volume":"30","author":"Seifert","year":"2016","journal-title":"Leukemia"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:20:51Z","timestamp":1776183651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683726000097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0023683726000097"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106079","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Resolution Spatial Transcriptomic Characterization of Syncytial Variant of Nodular Sclerosis Classical Hodgkin Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106079"}}